Cellectar Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
Presented updated data at the International Workshop for Waldenström Macroglobulinemia (IWWM) supporting the planned accelerated approval strategy for iopofosine I 131 in Waldenström macroglobulinemia (WM)
Covered in this story
Call it yourself
No calls on $WM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Waste Management →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.